Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,481 to 1,500 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01GM124072 | Structural determinants and functional consequences of protein partitioning to ordered membrane microdomains | 1 | 2019 |
| R01HD086327 | Placenta-derived extracellular circulating RNA as a tool for monitoring placental function | 1 | 2019 |
| R01HD089685 | Maternal molecular profiles reflect placental function and development across gestation | 1 | 2019 |
| R01HG009269 | Single-molecule systems for decoding combinatorial chromatin modifications | 1 | 2019 |
| R01HL128439 | Genetic Control of Airway Epithelium Gene Expression in Childhood Asthmatics | 1 | 2019 |
| R01HL130018 | Mechanisms of Glycosaminoglycan-Catalyzed Protease Inactivation by Serpins | 1 | 2019 |
| R01HL132950 | Checkpoint Function of PTPalpha in Pathological Fibrogenesis in the Lung | 1 | 2019 |
| R01HL133153 | Targeting Cell-specific Functions of the Rho Kinase Pathway in Pulmonary Fibrosis | 1 | 2019 |
| R01NS030843 | T cell response to myelin proteolipid protein | 1 | 2019 |
| R03AG060182 | The Contribution of T cells to the Pathogenesis of Atherosclerosis in Older Adults | 1 | 2019 |
| R03AI131066 | Spatial and temporal profiling to unravel the host cell responses to hepatitis B virus infection | 1 | 2019 |
| R13CA249974 | African Caribbean Cancer Consortium Scientific and Training Conference | 1 | 2019 |
| R15GM131390 | Normalizing Gene Expression Data from Formalin-Fixed Paraffin-Embedded Samples | 1 | 2019 |
| R21AG055879 | Evaluation of Epigenetic Markers of Biologic Age to Predict Adverse Outcomes after Transplantation | 1 | 2019 |
| R21AI138258 | Can a modest change in regulation of NOD1 expression have a major impact on inflammation and gastric cancer? | 1 | 2019 |
| R21AI138552 | Defining Novel Cellular Correlates of Protection Against Human Malaria by CyTOF | 1 | 2019 |
| R21AI140406 | Neutralizing nanobodies as therapeutics for Dengue virus | 1 | 2019 |
| R21AI140491 | Identification and characterization of allosteric inhibitors of Zika protease by targeting the NS2B conformational change | 1 | 2019 |
| R21AI140930 | Tailored induction of HIV-1 specific immunity through engineered dendritic cell vaccines | 1 | 2019 |
| R21CA221702 | Directed Purinergic Signaling as Immunotherapy in Leukemia | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=75